IL1B and myeloid sarcoma: The elevated mRNA expression in the MS patient group compared to the control group in our study aligns with a previous study conducted in Iran, reporting significantly higher IL-1β mRNA expression levels in MS patients than in age- and sex-matched controls [24,25].